Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting (Q37795157)

23 August 2017

title

Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting (English)

1 reference

23 August 2017

Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting (English)

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

23 July 2024

0 references

1 reference

chronic lymphocytic leukemia

1 reference

Jan A. Burger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20883788

23 July 2024

language of work or name

1 reference

29 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1044579X10000830?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

https://api.elsevier.com/content/article/PII:S1044579X10000830?httpAccept=text/plain

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Seminars in Cancer Biology

23 July 2024

published in

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

424-430

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

23 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35000501

Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist

1

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chemokines: new ligands, receptors and activities

23 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chemokines: a new classification system and their role in immunity

23 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Lymphocyte homing and homeostasis

23 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chemokines and leukocyte traffic

23 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Lymphocyte traffic control by chemokines

23 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Stromal cell contributions to the homeostasis and functionality of the immune system.

23 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

23 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chemokines and the arrest of lymphocytes rolling under flow conditions.

23 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

23 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Differential expression of chemokine receptors in B cell malignancies

23 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease

23 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma

23 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle.

23 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia

23 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes

23 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

23 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha

23 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)

23 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

23 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

23 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.

23 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

23 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential

23 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.

23 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

23 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

23 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

23 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

23 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

23 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

23 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Bruton's Tyrosine Kinase and Phospholipase Cγ2 Mediate Chemokine-Controlled B Cell Migration and Homing

23 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Follicular shuttling of marginal zone B cells facilitates antigen transport

23 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity

23 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma

23 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen

23 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1

23 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

23 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Imaging of germinal center selection events during affinity maturation

23 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

In vivo imaging of germinal centres reveals a dynamic open structure

23 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes

23 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

23 July 2024

B-1 B cell development

49

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia

23 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC

23 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

23 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The peritoneal micromilieu commits B cells to home to body cavities and the small intestine

23 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination

23 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia

23 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Lymphoid neogenesis in chronic inflammatory diseases.

23 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis.

23 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CXCR3, inflammation, and autoimmune diseases.

23 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization

23 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.

23 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells

23 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CCR7 and its ligands: balancing immunity and tolerance

23 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling

23 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CCR7 regulates lymphocyte egress and recirculation through body cavities.

23 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration

23 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.

23 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.

23 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes

23 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes.

23 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Comprehensive assessment of chemokine expression profiles by flow cytometry

23 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

23 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

23 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

23 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma

23 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma

23 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation

23 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival

23 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease

23 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

23 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions

23 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells

23 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

B cells and professional APCs recruit regulatory T cells via CCL4

23 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

23 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22

23 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

23 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia

23 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

23 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

23 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege

23 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells

23 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival

23 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia

23 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

23 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

Moving targets: cell migration inhibitors as new anti-inflammatory therapies

23 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.SEMCANCER.2010.09.005

23 July 2024

Identifiers

1 reference

23 August 2017

1 reference